Back to Eccles Lab
Our research focuses on several areas:
- Novel therapeutic mechanisms and biomarkers, including for immune checkpoint inhibitor therapy for cancer, and for polycystic kidney disease.
- Lymphangioleiomyomatosis (LAM). Non-small cell lung cancer (NSCLC).
- Epigenetic mechanisms in cancer, including microRNAs, and therapeutic targets for cancer treatment.
- Epigenetic and genetic mechanisms involved in abnormalities of the kidney, particularly polycystic kidney disease.
The main project areas are as follows; Six current project areas (and associated staff) are; 1) Breast cancer (Magda, Suzan, Mike) 2) Melanoma (Mehbuba, Peter S., Suzan, Lorissa, Mike) 3) Lung cancer and kidney cancer (Magda, Lei, Mike) 4) LAM and PKD (Ryan, Erin, Qi, Cherie) 5) Marsden on-going (Chi, Erin, Lorissa, Katie, Mike) 6) MicroRNAs (Lei, Qi, Mehbuba, Mike)